ArticlePloS one2026

Nintedanib in the prevention of radiation-induced lung injury in patients with unresectable stage II-III NSCLC: A protocol for a randomized, multicenter, control group study.

Ai Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.